AbbVie (Germany)
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. It is ranked sixth on the list of largest biomedical companies by revenue. In 2023, the company's seat in Forbes Global 2000 was 74. The company's primary product is Humira, administered via injection. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for AbbVie (Germany), Germany, covering academic research published from 2013 to 2023. Read More.
Open Access Percentage
60%
Total
Publications
892
Total Open
Publications
538
Total
Citations
17K
Open Access
Percentage
60%
Total
Publications
892
Total Open
Publications
538
Total
Citations
17K
Breakdown
Publisher Open
26%
Both
30%
Other Platform Open
4%
Closed
40%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 29%
145
Hybrid 32%
162
No Guarantees 39%
194
Other Platform Open
Domain 80%
241
Institution 33%
101
Preprint 10%
30
Other Internet 7%
21
Public 5%
16
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 240 |
Europe PMC | Domain | 103 |
University College London - UCL Discovery | Institution | 23 |
bioRxiv | Preprint | 20 |
Radboud University - Radboud Repository | Institution | 17 |
KU Leuven - Lirias | Institution | 17 |
University of Bristol - Bristol Research | Institution | 12 |
Semantic Scholar | Public | 12 |
Erasmus University Rotterdam - EUR Research Repository | Institution | 11 |
University of Oxford - Oxford University Research Archive (ORA) | Institution | 7 |